Literature DB >> 19763595

Identification of polymorphisms in the Toll-like receptor gene and the association with allergic rhinitis.

Inhong Kang1, Yeon-Kyun Oh, Sang Heon Lee, Ha Min Jung, Soo-Cheon Chae, Jae Hoon Lee.   

Abstract

The TLRs gene encodes the principal innate immunity receptor in humans. The TLR2 Arg753Gln and Arg677Trp polymorphisms have been associated with a reduced response of monocytes and cell lines to challenge with mycobacteria. The TLR4 Asp299Gly and Thr399Ile polymorphisms have been associated with a reduction in the inflammatory responses to lipopolysaccharide in humans. It has been suggested that TLR2 and TLR4 polymorphisms may be associated with allergic responses; thus, we hypothesized that TLR2 and TLR4 polymorphisms may modify the relative risk for development of allergic rhinitis. The Taqman assay and high-resolution melt (HRM) were used for genotyping. We analyzed two single nucleotide polymorphisms (SNPs; 597T>C and 1350T>C) in the TLR2 gene and 1 SNP (4216G>C) in the TLR4 gene. We compared the genotype of these SNPs in patients with allergic rhinitis and controls without allergic rhinitis. We also estimated the haplotype frequencies between the two groups. The genotype and allele frequencies of the 597T>C and 1350T>C SNPs in the TLR2 gene were not significantly different between the patients with allergic rhinitis and controls (P > 0.05). The genotype and allele frequencies of 4216G>C in the TLR4 gene were not significantly different between the patients with allergic rhinitis and controls (P > 0.05). Haplotype analysis of the following two different (597)-(1350) major haplotypes (frequency >0.05) were present in the TLR2 gene: T-C and C-C. The C-C haplotype was positively associated with allergic rhinitis (P = 0.048). Our study suggests that the TLR2 gene polymorphisms might be susceptible to the development of allergic rhinitis. Further functional studies of TLR2 genetics in light of the associations with allergic rhinitis inflammation would help clarify the role of TLR2 genetics in clinical evaluations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763595     DOI: 10.1007/s00405-009-1100-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  17 in total

Review 1.  The Toll receptor family and microbial recognition.

Authors:  R Medzhitov; C Janeway
Journal:  Trends Microbiol       Date:  2000-10       Impact factor: 17.079

Review 2.  Family size, infection and atopy: the first decade of the "hygiene hypothesis".

Authors:  D P Strachan
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

3.  An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population.

Authors:  E Noguchi; F Nishimura; H Fukai; J Kim; K Ichikawa; M Shibasaki; T Arinami
Journal:  Clin Exp Allergy       Date:  2004-02       Impact factor: 5.018

4.  Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes.

Authors:  Lutz Hamann; Axel Hamprecht; Abuzeid Gomma; Ralf R Schumann
Journal:  J Immunol Methods       Date:  2004-02-15       Impact factor: 2.303

5.  Lack of association between Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczema.

Authors:  Stephan Weidinger; Natalija Novak; Norman Klopp; Hansjörg Baurecht; Stefan Wagenpfeil; Lars Rummler; Johannes Ring; Heidrun Behrendt; Thomas Illig
Journal:  J Allergy Clin Immunol       Date:  2006-06-06       Impact factor: 10.793

6.  Toll-like receptor heterodimer variants protect from childhood asthma.

Authors:  Michael S D Kormann; Martin Depner; Dominik Hartl; Norman Klopp; Thomas Illig; Jerzy Adamski; Christian Vogelberg; Stephan K Weiland; Erika von Mutius; Michael Kabesch
Journal:  J Allergy Clin Immunol       Date:  2008-06-10       Impact factor: 10.793

Review 7.  The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

Authors:  Sergio Romagnani
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

8.  Toll-like receptor 2 as a major gene for asthma in children of European farmers.

Authors:  Waltraud Eder; Walt Klimecki; Lizhi Yu; Erika von Mutius; Josef Riedler; Charlotte Braun-Fahrländer; Dennis Nowak; Fernando D Martinez
Journal:  J Allergy Clin Immunol       Date:  2004-03       Impact factor: 10.793

9.  Toll-like receptor 4 polymorphism and severity of atopy in asthmatics.

Authors:  I A Yang; S J Barton; S Rorke; J A Cakebread; T P Keith; J B Clough; S T Holgate; J W Holloway
Journal:  Genes Immun       Date:  2004-01       Impact factor: 2.676

Review 10.  Toll-like receptors in the pathogenesis of human disease.

Authors:  Donald N Cook; David S Pisetsky; David A Schwartz
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

View more
  7 in total

1.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

2.  Association of TLR-4 and TNF-alpha polymorphisms with clinical symptoms and cytokine levels in patients with allergic rhinitis.

Authors:  Magdolna Krasznai; Kinga Szaniszlo; Helga Kraxner; Eszter Vargha; Margit Kovacs; Zoltan Borocz; Edit Kaszas; Gyorgyi Mezei; Endre Cserhati; Karoly Cseh
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-20       Impact factor: 2.503

3.  A meta-analysis of Th2 pathway genetic variants and risk for allergic rhinitis.

Authors:  Supinda Bunyavanich; Josef Shargorodsky; Juan C Celedón
Journal:  Pediatr Allergy Immunol       Date:  2011-02-10       Impact factor: 6.377

4.  A case-control study of innate immunity pathway gene polymorphisms in Puerto Ricans reveals association of toll-like receptor 2 +596 variant with asthma.

Authors:  Mario G Ortiz-Martínez; Orquídea Frías-Belén; Sylvette Nazario-Jiménez; María López-Quintero; Rosa I Rodríguez-Cotto; Braulio D Jiménez-Vélez
Journal:  BMC Pulm Med       Date:  2016-08-05       Impact factor: 3.317

5.  TLR Signaling Pathway Gene Polymorphisms, Gene-Gene and Gene-Environment Interactions in Allergic Rhinitis.

Authors:  Ruo-Xi Chen; Meng-Di Dai; Qing-Zhao Zhang; Mei-Ping Lu; Mei-Lin Wang; Min Yin; Xin-Jie Zhu; Zhong-Fei Wu; Zheng-Dong Zhang; Lei Cheng
Journal:  J Inflamm Res       Date:  2022-06-22

6.  Toll-like receptor gene polymorphisms are associated with allergic rhinitis: a case control study.

Authors:  Daniel Nilsson; Anand Kumar Andiappan; Christer Halldén; Wang De Yun; Torbjörn Säll; Chew Fook Tim; Lars-Olaf Cardell
Journal:  BMC Med Genet       Date:  2012-08-02       Impact factor: 2.103

7.  Allergic rhinitis and genetic components: focus on Toll-like receptors (TLRs) gene polymorphism.

Authors:  Zhiwei Gao; Donna C Rennie; Ambikaipakan Senthilselvan
Journal:  Appl Clin Genet       Date:  2010-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.